EUVIMEDEUVIMED entdecken
Crossref

LncRNA CTB-31O20.2 promotes the progression of hepatocellular carcinoma by targeting the miR-139-5p/ROCK1 axis

Dizhong Ye, Biyan Chen, Xiangfa Wang, Weiwei Chen, Feng Ye, Guangqian Quan

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Dizhong Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China. Hauptthemen laut MEDLINE: MicroRNAs, rho-Associated Kinases, Carcinoma, Hepatocellular, RNA, Long Noncoding. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a primary cause of mortality from cancer, necessitating novel insights into its molecular underpinnings. Recent evidence points to the significant roles of lncRNAs in HCC progression, among which CTB-31O20.2 has emerged as a potentially crucial player. This study utilized RNA sequencing to identify differentially expressed lncRNAs in HCC tissues, focusing on CTB-31O20.2. We employed RT-qPCR, Western blotting, and dual-luciferase reporter assays to evaluate the expression patterns of CTB-31O20.2 in HCC cells and its interactions with miR-139-5p and Rho-associated coiled-coil containing protein kinase1 (ROCK1). In vivo effects were analyzed using a xenograft mouse model. CTB-31O20.2 was significantly upregulated in HCC tissues and cell lines. Silencing CTB-31O20.2 in Hep3B and HepG2 cells reduced malignancy, evidenced by decreased viability, colony formation, and invasion, and increased apoptosis. These cellular behaviors were associated with alterations in apoptosis-related proteins and epithelial-mesenchymal transition (EMT) markers. CTB-31O20.2 was shown to interact with miR-139-5p, and its silencing upregulated miR-139-5p, leading to reduced ROCK1 expression. Conversely, miR-139-5p inhibition reversed the anti-tumor effects of CTB-31O20.2 silencing. Overexpression of ROCK1 negated the inhibitory effects on HCC cell malignancy induced by CTB-31O20.2 depletion. In vivo, CTB-31O20.2 silencing significantly reduced tumor growth in a xenograft model. Our findings reveal that CTB-31O20.2 contributes to HCC progression by modulating miR-139-5p and ROCK1 expression. These results highlight CTB-31O20.2 as a potential therapeutic target in HCC, providing a new perspective on the mechanisms driving HCC pathogenesis and progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsrho-Associated KinasesCarcinoma, HepatocellularRNA, Long NoncodingLiver NeoplasmsHumansAnimalsMiceDisease ProgressionGene Expression Regulation, NeoplasticMaleCell Line, TumorMice, NudeEpithelial-Mesenchymal TransitionHep G2 CellsMice, Inbred BALB CFemaleApoptosis

Stichwörter der Autor:innen

CTB-31O20.2EMTHepatocellular carcinomaROCK1miR-139-5p

Substanzen

MicroRNAsrho-Associated KinasesRNA, Long NoncodingMIRN139 microRNA, humanROCK1 protein, human

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China.
  • Department of Thyroid and Breast Surgery, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China. Electronic address: quanguangqian_ye@sina.com.

Förderung

  • Natural Science Foundation of Fujian Province
  • Fujian Medical University

Zitieren

APA

Ye, D., Chen, B., Wang, X., Chen, W., Ye, F., & Quan, G. (2025). LncRNA CTB-31O20.2 promotes the progression of hepatocellular carcinoma by targeting the miR-139-5p/ROCK1 axis. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110619

Vancouver

Ye D, Chen B, Wang X, Chen W, Ye F, Quan G. LncRNA CTB-31O20.2 promotes the progression of hepatocellular carcinoma by targeting the miR-139-5p/ROCK1 axis. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110619

BibTeX
@article{Ye2025,
  author = {Ye, Dizhong and Chen, Biyan and Wang, Xiangfa and Chen, Weiwei and Ye, Feng and Quan, Guangqian},
  title = {LncRNA CTB-31O20.2 promotes the progression of hepatocellular carcinoma by targeting the miR-139-5p/ROCK1 axis},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110619}
}
Kostenlos starten →